Aarti Drugs Q4 Results: Profit Jumps 33%

The margin narrowed to 13.8% in the quarter ended March.

Aarti Drugs Ltd. consolidated net profit grew 33% in the fourth quarter of the last financial year (Image: company website)

Aarti Drugs Ltd. consolidated net profit grew 33% in the fourth quarter of the last financial year.

The pharmaceutical company posted a profit of Rs 63 crore in the quarter ended March, according to an exchange filing on Tuesday.

Aarti Drugs Q4 FY25 Highlights (Consolidated, YoY)

  • Revenue up 9% to Rs 676 crore versus Rs 620 crore.

  • Ebitda up 8% to Rs 93.2 crore versus Rs 86.1 crore.

  • Margin narrows to 13.8% versus 13.9%.

  • Net profit up 33% to Rs 63 crore versus Rs 47.4 crore.

Also Read: HPCL Q4 Results: Net Profit Rises 11%; Final Dividend Declared

Shares of Aarti Drugs closed 1.45% lower at Rs 349.9 apiece on the National Stock Exchange before the results were announced, compared to a 0.33% decline in the benchmark Nifty.

Also Read: Q4 Results: Mahanagar Gas Earnings Meet Estimates; BSE Profit More Than Doubles; NSE Earnings Down

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit.
WRITTEN BY
Ann Jacob
Ann Jacob tracks markets with a special focus on personal finance. She clos... more
GET REGULAR UPDATES